177 related articles for article (PubMed ID: 25320359)
1. ABO blood group IgM isoagglutinins interact with tumor-associated O-glycan structures in pancreatic cancer.
Hofmann BT; Stehr A; Dohrmann T; Güngör C; Herich L; Hiller J; Harder S; Ewald F; Gebauer F; Tachezy M; Precht C; Izbicki JR; Bockhorn M; Wagener C; Wolters-Eisfeld G
Clin Cancer Res; 2014 Dec; 20(23):6117-26. PubMed ID: 25320359
[TBL] [Abstract][Full Text] [Related]
2. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer.
Hofmann BT; Schlüter L; Lange P; Mercanoglu B; Ewald F; Fölster A; Picksak AS; Harder S; El Gammal AT; Grupp K; Güngör C; Drenckhan A; Schlüter H; Wagener C; Izbicki JR; Jücker M; Bockhorn M; Wolters-Eisfeld G
Mol Cancer; 2015 May; 14():109. PubMed ID: 26021314
[TBL] [Abstract][Full Text] [Related]
3. Early ovariectomy reveals the germline encoding of natural anti-A- and Tn-cross-reactive immunoglobulin M (IgM) arising from developmental O-GalNAc glycosylations. (Germline-encoded natural anti-A/Tn cross-reactive IgM).
Arend P
Cancer Med; 2017 Jul; 6(7):1601-1613. PubMed ID: 28580709
[TBL] [Abstract][Full Text] [Related]
4. ABO (histo) blood group phenotype development and human reproduction as they relate to ancestral IgM formation: A hypothesis.
Arend P
Immunobiology; 2016 Jan; 221(1):116-27. PubMed ID: 26433867
[TBL] [Abstract][Full Text] [Related]
5. MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans.
Sagar S; Leiphrakpam PD; Thomas D; McAndrews KL; Caffrey TC; Swanson BJ; Clausen H; Wandall HH; Hollingsworth MA; Radhakrishnan P
Cancer Lett; 2021 Apr; 503():91-102. PubMed ID: 33485947
[TBL] [Abstract][Full Text] [Related]
6. Complementary innate (anti-A-specific) IgM emerging from ontogenic O-GalNAc-transferase depletion: (Innate IgM complementarity residing in ancestral antigen completeness).
Arend P
Immunobiology; 2014 Apr; 219(4):285-91. PubMed ID: 24290972
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody signature in human ductal pancreatic adenocarcinoma.
Tomaino B; Cappello P; Capello M; Fredolini C; Ponzetto A; Novarino A; Ciuffreda L; Bertetto O; De Angelis C; Gaia E; Salacone P; Milella M; Nisticò P; Alessio M; Chiarle R; Giuffrida MG; Giovarelli M; Novelli F
J Proteome Res; 2007 Oct; 6(10):4025-31. PubMed ID: 17824682
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of core 3 O-glycan synthetic enzyme, β1,3-N-acetylglucosaminyltransferase 6 in pancreatic ductal adenocarcinoma.
Doi N; Ino Y; Angata K; Shimada K; Narimatsu H; Hiraoka N
PLoS One; 2020; 15(11):e0242851. PubMed ID: 33253272
[TBL] [Abstract][Full Text] [Related]
9. Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation.
Chugh S; Meza J; Sheinin YM; Ponnusamy MP; Batra SK
Br J Cancer; 2016 Jun; 114(12):1376-86. PubMed ID: 27187683
[TBL] [Abstract][Full Text] [Related]
10. Intra-tumoral IFN-γ-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer.
Niccolai E; Taddei A; Ricci F; Rolla S; D'Elios MM; Benagiano M; Bechi P; Bencini L; Ringressi MN; Pini A; Castiglione F; Giordano D; Satolli MA; Coratti A; Cianchi F; Bani D; Prisco D; Novelli F; Amedei A
Clin Sci (Lond); 2016 Feb; 130(4):247-58. PubMed ID: 26590104
[TBL] [Abstract][Full Text] [Related]
11. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic adenocarcinoma exerts systemic effects on the peripheral blood myeloid and plasmacytoid dendritic cells: an indicator of disease severity?
Tjomsland V; Sandström P; Spångeus A; Messmer D; Emilsson J; Falkmer U; Falkmer S; Magnusson KE; Borch K; Larsson M
BMC Cancer; 2010 Mar; 10():87. PubMed ID: 20214814
[TBL] [Abstract][Full Text] [Related]
13. The mucinous domain of pancreatic carboxyl-ester lipase (CEL) contains core 1/core 2
El Jellas K; Johansson BB; Fjeld K; Antonopoulos A; Immervoll H; Choi MH; Hoem D; Lowe ME; Lombardo D; Njølstad PR; Dell A; Mas E; Haslam SM; Molven A
J Biol Chem; 2018 Dec; 293(50):19476-19491. PubMed ID: 30315106
[TBL] [Abstract][Full Text] [Related]
14. Quantitative structural analysis of glycans expressed within tumors derived from pancreatic cancer patient-derived xenograft mouse models.
Hasehira K; Furuta T; Shimomura O; Asada M; Oda T; Tateno H
Biochem Biophys Res Commun; 2021 Jan; 534():310-316. PubMed ID: 33288196
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of leukemia inhibitory factor in human pancreatic cancer].
Peng F; Zhou J; Sheng W; Zhang D; Dong M
Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):90-5. PubMed ID: 24721346
[TBL] [Abstract][Full Text] [Related]
16. Multivariate data analysis for the detection of human alpha-acid glycoprotein aberrant glycosylation in pancreatic ductal adenocarcinoma.
Mancera-Arteu M; Giménez E; Balmaña M; Barrabés S; Albiol-Quer M; Fort E; Peracaula R; Sanz-Nebot V
J Proteomics; 2019 Mar; 195():76-87. PubMed ID: 30641231
[TBL] [Abstract][Full Text] [Related]
17. ABO blood groups and isoagglutinins in systemic lupus erythematosus.
Ottensooser F; Leon N; de Almeida TV
Rev Bras Pesqui Med Biol; 1975; 8(5-6):421-5. PubMed ID: 1241149
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of fibroblast growth factor receptor 4 in high-grade pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
Motoda N; Matsuda Y; Onda M; Ishiwata T; Uchida E; Naito Z
Int J Oncol; 2011 Jan; 38(1):133-43. PubMed ID: 21109934
[TBL] [Abstract][Full Text] [Related]
19. Nondeletional ABO*O alleles frequently cause blood donor typing problems.
Wagner FF; Blasczyk R; Seltsam A
Transfusion; 2005 Aug; 45(8):1331-4. PubMed ID: 16078922
[TBL] [Abstract][Full Text] [Related]
20. Imaging Mass Spectrometry and Lectin Analysis of N-Linked Glycans in Carbohydrate Antigen-Defined Pancreatic Cancer Tissues.
McDowell CT; Klamer Z; Hall J; West CA; Wisniewski L; Powers TW; Angel PM; Mehta AS; Lewin DN; Haab BB; Drake RR
Mol Cell Proteomics; 2021; 20():100012. PubMed ID: 33581409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]